
AbbVie's tavapadon could become DRI Healthcare Trust’s largest royalty asset
<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxOcVI5ZHdtNzhCc1cyYjhMb0JLT2VhQlZtajM1dUhxRmNUVXA0WmtrWnpwNmI1dzkzejBlcFI0TnB3SnFtOWdnMW5XdnpMUHdISnV1TDNPUDh6VC1yVGNpQjhYY3Nxb3RkM3lSNm1OLTFlYVIzRFZreXZlX05lYVFHalA1cjZqT0dkd2tCM2NsYjlNMERxeDVFVVk4S082dGwxZ0JNVWhyanl2NGdseUExVEtKRlkxMjI1YW8zU2ZNUkdaLWJ0a3ZIeUlRZlFwQjV2WDQtTDVWY1A5TjcwREZ6cG9acmZkY3lQbmNn?oc=5" target="_blank">AbbVie's tavapadon could become DRI Healthcare Trust’s largest royalty asset</a>&nbsp;&nbsp;<font color="#6f6f6f">S&P Global</font>

